Wednesday, April 18, 2012

Vol. 18, No. 8

TRIGGER
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 18, No. 8  April 16, 2012
(The next issue will be on May 1, 2012)
__________________________________________________________
TRIGGER is also available by RSS Feed:
and BLOG:
http://trigger-tf7.blogspot.com/
__________________________________________________________
PAPERS IN PRESS
None submitted for this issue.
__________________________________________________________
RECENT PUBLICATIONS ON TISSUE FACTOR, FACTOR VII, AND TFPI
Papers are culled from NLM MedLine (PubMed). Titles in square brackets indicate that the paper was not published in English. References that lack volume or page numbers are typically electronic pre-publications (E-pubs) ahead of the print publication; if so, the final citation with volume and page numbers may or may not appear in a future issue of Trigger.
THE FOLLOWING LINK WILL TAKE YOU TO THE ENTIRE LIST OF THIS ISSUE'S PUBLICATIONS IN A PUBMED "COLLECTION":
http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/1hGga96FNmQq0-Jjci6y9hi/

Adams MJ, Palatinus AA, Harvey AM, Khalafallah AA (2011) Impaired control of the tissue factor pathway of blood coagulation in systemic lupus erythematosus. Lupus 20:1474-1483.
http://www.ncbi.nlm.nih.gov/pubmed/21993387

Ahonen J (2012) The role of recombinant activated factor VII in obstetric hemorrhage. Curr Opin Anaesthesiol.
http://www.ncbi.nlm.nih.gov/pubmed/22473215

Augoustides JG (2011) Advances in anticoagulation: focus on dabigatran, an oral direct thrombin inhibitor. J Cardiothorac Vasc Anesth 25:1208-1212.
http://www.ncbi.nlm.nih.gov/pubmed/21982327

Benesic A, Rahm NL, Ernst S, Gerbes AL (2012) Human monocyte-derived cells with individual hepatocyte characteristics: a novel tool for personalized in vitro studies. Lab Invest.
http://www.ncbi.nlm.nih.gov/pubmed/22469698

Blanco FJ, Bernabeu C (2012) The Splicing Factor SRSF1 as a Marker for Endothelial Senescence. Front Physiol 3:54.
http://www.ncbi.nlm.nih.gov/pubmed/22470345

Brown CV, Sowery L, Curry E, Valadka AB, Glover CS, Grabarkewitz K, . . . Admire J (2012) Recombinant factor VIIa to correct coagulopathy in patients with traumatic brain injury presenting to outlying facilities before transfer to the regional trauma center. Am Surg 78:57-60.
http://www.ncbi.nlm.nih.gov/pubmed/22273315

Changlani DK, Devendaran V, Murmu UC, Ganesan S, Varghese R, Kumar RS (2012) Factor VII for excessive bleeding following congenital heart disease surgery. Asian Cardiovasc Thorac Ann 20:120-125.
http://www.ncbi.nlm.nih.gov/pubmed/22499956

Chen J, Duan ZP, Bai L, Zhao J, Ding M, Tong XY, Cong YL (2012) [Changing characteristic of blood coagulation factors and their correlation with blood coagulation status in different hepatic diseases]. Zhonghua Gan Zang Bing Za Zhi 20:206-210.
http://www.ncbi.nlm.nih.gov/pubmed/22475141

Christensen A, Jensen JT, Nohr AM, Cooper DL (2011) Room-temperature-stable recombinant activated coagulation factor VII recombinant: chemical and microbiologic stability over 24 hours during continuous in vitro infusion. Clin Ther 33:1997-2001.
http://www.ncbi.nlm.nih.gov/pubmed/22088413

Corlan AD, Ross J (2011) Canalization effect in the coagulation cascade and the interindividual variability of oral anticoagulant response. A simulation study. Theor Biol Med Model 8:37.
http://www.ncbi.nlm.nih.gov/pubmed/22082142

de Paula EV, Kavakli K, Mahlangu J, Ayob Y, Lentz SR, Morfini M, . . . Chuansumrit A (2012) Recombinant factor VIIa analog (vatreptacog alfa [activated]) for treatment of joint bleeds in hemophilia patients with inhibitors: a randomized controlled trial. J Thromb Haemost 10:81-89.
http://www.ncbi.nlm.nih.gov/pubmed/22470921

Dolan G, Cruz JA, Steinhagen-Thiessen E, Kessler C, Haaning J, Lemm G, . . . Bolton-Maggs P (2012) Advances in hemophilia care: report of two symposia at the hemophilia 2010 world congress. Adv Ther 29 Suppl 1:1-16.
http://www.ncbi.nlm.nih.gov/pubmed/22467446

Eisenreich A, Rauch U (2010) Regulation and differential role of the tissue factor isoforms in cardiovascular biology. Trends Cardiovasc Med 20:199-203.
http://www.ncbi.nlm.nih.gov/pubmed/22137642

Emin MT, Sun L, Huertas A, Das S, Bhattacharya J, Bhattacharya S (2012) Platelets induce endothelial tissue factor expression in a mouse model of acid-induced lung injury. Am J Physiol Lung Cell Mol Physiol.
http://www.ncbi.nlm.nih.gov/pubmed/22505671

Foster DJ, Barros S, Duncan R, Shaikh S, Cantley W, Dell A, . . . Elbashir SM (2012) Comprehensive evaluation of canonical versus Dicer-substrate siRNA in vitro and in vivo. RNA 18:557-568.
http://www.ncbi.nlm.nih.gov/pubmed/22294662

Francischetti IM, Oliveira CJ, Ostera GR, Yager SB, Debierre-Grockiego F, Carregaro V, . . . Waisberg M (2012) Defibrotide interferes with several steps of the coagulation-inflammation cycle and exhibits therapeutic potential to treat severe malaria. Arterioscler Thromb Vasc Biol 32:786-798.
http://www.ncbi.nlm.nih.gov/pubmed/22116094

Ganetsky M, Babu KM, Salhanick SD, Brown RS, Boyer EW (2011) Dabigatran: review of pharmacology and management of bleeding complications of this novel oral anticoagulant. J Med Toxicol 7:281-287.
http://www.ncbi.nlm.nih.gov/pubmed/21887485

Gaud G, Iochmann S, Guillon-Munos A, Brillet B, Petiot S, Seigneuret F, . . . Reverdiau P (2011) TFPI-2 silencing increases tumour progression and promotes metalloproteinase 1 and 3 induction through tumour-stromal cell interactions. J Cell Mol Med 15:196-208.
http://www.ncbi.nlm.nih.gov/pubmed/20015200

Giblin P, Boxhammer R, Desai S, Kroe-Barrett R, Hansen G, Ksiazek J, . . . Litzenburger T (2011) Fully human antibodies against the Protease-Activated Receptor-2 (PAR-2) with anti-inflammatory activity. Hum Antibodies 20:83-94.
http://www.ncbi.nlm.nih.gov/pubmed/22129678

Girard TJ, Tuley E, Broze GJ, Jr. (2012) TFPIbeta is the GPI-anchored TFPI isoform on human endothelial cells and placental microsomes. Blood 119:1256-1262.
http://www.ncbi.nlm.nih.gov/pubmed/22144186

Godby RC, Van Den Berg YW, Srinivasan R, Sturm R, Hui DY, Konieczny SF, . . . Bogdanov VY (2012) Non-Proteolytic Properties of Murine Alternatively Spliced Tissue Factor: Implications for Integrin-Mediated Signaling in Murine Models. Mol Med.
http://www.ncbi.nlm.nih.gov/pubmed/22481268

Grabowski EF, Yam K, Gerace M (2012) Evaluation of hemostasis in flowing blood. Am J Hematol.
http://www.ncbi.nlm.nih.gov/pubmed/22495911

Haynes LM, Dubief YC, Mann KG (2012) Membrane binding events in the initiation and propagation phases of tissue factor-initiated zymogen activation under flow. J Biol Chem 287:5225-5234.
http://www.ncbi.nlm.nih.gov/pubmed/22187432

Higuchi Y, Kubota T, Koyanagi M, Maeda T, Feldman AM, Makino N (2012) The Upregulation of Anticoagulant Proteins, Protein S and Tissue Factor Pathway Inhibitor, in the Mouse Myocardium with Cardio-Specific TNF-alpha Overexpression. Am J Physiol Heart Circ Physiol.
http://www.ncbi.nlm.nih.gov/pubmed/22492716

Holroyd EW, Delacroix S, Larsen K, Harbuzariu A, Psaltis PJ, Wang L, . . . Simari RD (2012) Tissue factor pathway inhibitor blocks angiogenesis via its carboxyl terminus. Arterioscler Thromb Vasc Biol 32:704-711.
http://www.ncbi.nlm.nih.gov/pubmed/22223730

Hossain N, Shansi T, Haider S, Soomro N, Khan NH, Memon GU, . . . Paidas MJ (2007) Use of recombinant activated factor VII for massive postpartum hemorrhage. Acta Obstet Gynecol Scand 86:1200-1206.
http://www.ncbi.nlm.nih.gov/pubmed/17851797

Howard BM, Daley AT, Cohen MJ (2012) Prohemostatic Interventions in Trauma: Resuscitation-Associated Coagulopathy, Acute Traumatic Coagulopathy, Hemostatic Resuscitation, and Other Hemostatic Interventions. Semin Thromb Hemost.
http://www.ncbi.nlm.nih.gov/pubmed/22467527

Huang XX, Pang BS, Yang YH, Zhang HY, Guo SL (2011) [Change of coagulation functions and its significance in acute exacerbation of chronic obstructive pulmonary disease]. Zhonghua Yi Xue Za Zhi 91:1543-1545.
http://www.ncbi.nlm.nih.gov/pubmed/21914367

Imanishi T, Akasaka T (2012) Biomarkers associated with vulnerable atheromatous plaque. Curr Med Chem.
http://www.ncbi.nlm.nih.gov/pubmed/22489722

Joseph B, Amini A, Friese RS, Houdek M, Hays D, Kulvatunyou N, . . . Rhee P (2012) Factor IX complex for the correction of traumatic coagulopathy. J Trauma Acute Care Surg 72:828-834.
http://www.ncbi.nlm.nih.gov/pubmed/22491593

Knottnerus IL, Winckers K, Ten Cate H, Hackeng TM, Lodder J, Rouhl RP, . . . van Oostenbrugge RJ (2012) Levels of heparin-releasable TFPI are increased in first-ever lacunar stroke patients. Neurology 78:493-498.
http://www.ncbi.nlm.nih.gov/pubmed/22302552

Krijnen PA, Hahn NE, Kholova I, Baylan U, Sipkens JA, van Alphen FP, . . . Niessen HW (2012) Loss of DPP4 activity is related to a prothrombogenic status of endothelial cells: implications for the coronary microvasculature of myocardial infarction patients. Basic Res Cardiol 107:1-13.
http://www.ncbi.nlm.nih.gov/pubmed/22167343

Krisl JC, Meadows HE, Greenberg CS, Mazur JE (2011) Clinical usefulness of recombinant activated factor VII in patients with liver failure undergoing invasive procedures. Ann Pharmacother 45:1433-1438.
http://www.ncbi.nlm.nih.gov/pubmed/22009992

Lesperance RN, Lehmann RK, Harold DM, Beekley AC, Sebesta JA, Martin MJ (2012) Recombinant factor VIIa is effective at reversing coagulopathy in a lactic acidosis model. J Trauma Acute Care Surg 72:123-129.
http://www.ncbi.nlm.nih.gov/pubmed/22002618

Levi M, van der Poll T, Schultz M (2012) Systemic versus localized coagulation activation contributing to organ failure in critically ill patients. Semin Immunopathol 34:167-179.
http://www.ncbi.nlm.nih.gov/pubmed/21805225

Li P, Yang Y, Liu M (2011) Xuezhikang, extract of red yeast rice, inhibited tissue factor and hypercoagulable state through suppressing nicotinamide adenine dinucleotide phosphate oxidase and extracellular signal-regulated kinase activation. J Cardiovasc Pharmacol 58:307-318.
http://www.ncbi.nlm.nih.gov/pubmed/21697731

Li R, Ren M, Luo M, Chen N, Zhang Z, Luo B, Wu J (2012) Monomeric C-reactive protein alters fibrin clot properties on endothelial cells. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/22475312

Marlu R, Polack B (2012) Gla-domainless factor Xa: molecular bait to bypass a blocked tenase complex. Haematologica.
http://www.ncbi.nlm.nih.gov/pubmed/22491732

Meadows HB, Krisl JC, Greenberg CS, Mazur JE (2011) The use of activated recombinant factor VII in a patient with fulminant hepatic failure requiring placement of an intracranial pressure monitor. Ann Pharmacother 45:e60.
http://www.ncbi.nlm.nih.gov/pubmed/22028416

Mikovic D, Woodhams BJ, Holmstrom M, Elezovic I, Antovic A, Mobarrez F, . . . Antovic JP (2012) On-demand but not prophylactic treatment with FVIII concentrate increase thrombin activatable fibrinolysis inhibitor activation in severe haemophilia A patients. Int J Lab Hematol 34:35-40.
http://www.ncbi.nlm.nih.gov/pubmed/21707936

Olbrich P, Parrilla Parrilla J, Caballero Eraso C, Loscertales Abril M, Neth O (2012) Combined Use of Recombinant Activated Factor VII and ECMO in Severe Postoperative Bleeding after Cardiac Surgery in a Newborn: Death due to Ventricular Dysfunction. Klin Padiatr.
http://www.ncbi.nlm.nih.gov/pubmed/22504771

Orfeo T, Gissel M, Butenas S, Undas A, Brummel-Ziedins KE, Mann KG (2011) Anticoagulants and the propagation phase of thrombin generation. PLoS One 6:e27852.
http://www.ncbi.nlm.nih.gov/pubmed/22125631

Palmason R, Vidarsson B, Sigvaldason K, Ingimarsson JP, Gudbjartsson T, Sigurdsson GH, Onundarson PT (2012) Recombinant factor VIIa as last-resort treatment of desperate haemorrhage. Acta Anaesthesiol Scand 56:636-644.
http://www.ncbi.nlm.nih.gov/pubmed/22489992

Park JB, Kim BK, Kwon YW, Muller DN, Lee HC, Youn SW, . . . Kim HS (2011) Peroxisome proliferator-activated receptor-gamma agonists suppress tissue factor overexpression in rat balloon injury model with paclitaxel infusion. PLoS One 6:e28327.
http://www.ncbi.nlm.nih.gov/pubmed/22140576

Petricevic M, Biocina B, Konosic S, Burcar I (2012) Haemostatic management in high-risk cardiac surgery: a role of recombinant factor VIIa (Novoseven RT). Eur J Cardiothorac Surg.
http://www.ncbi.nlm.nih.gov/pubmed/22504897

Pucci A, Formato L, Muscio M, Brscic E, Pizzimenti S, Ferroni F, . . . Spinnler MT (2011) PPARgamma in coronary atherosclerosis: in vivo expression pattern and correlations with hyperlipidemic status and statin treatment. Atherosclerosis 218:479-485.
http://www.ncbi.nlm.nih.gov/pubmed/21726861

Pychynska-Pokorska M, Pagowska-Klimek I, Krajewski W, Moll JJ (2011) Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass. J Cardiothorac Vasc Anesth 25:987-994.
http://www.ncbi.nlm.nih.gov/pubmed/21835642

Raffa S, Reverter JC, Seijo S, Tassies D, Abraldes JG, Bosch J, Garcia-Pagan JC (2012) Hypercoagulability in patients with chronic noncirrhotic portal vein thrombosis. Clin Gastroenterol Hepatol 10:72-78.
http://www.ncbi.nlm.nih.gov/pubmed/21946303

Scola MR, Nichols TC, Zhu H, Caughey MC, Merricks EP, Raymer RA, . . . Gallippi CM (2011) ARFI ultrasound monitoring of hemorrhage and hemostasis in vivo in canine von Willebrand disease and hemophilia. Ultrasound Med Biol 37:2126-2132.
http://www.ncbi.nlm.nih.gov/pubmed/22033127

Sekiya A, Morishita E, Maruyama K, Asakura H, Nakao S, Ohtake S (2012) Significant decrease in factor VII activity by tissue thromboplastin derived from rabbit brain in a patient with congenital factor VII deficiency (FVII Padua). Rinsho Ketsueki 53:357-360.
http://www.ncbi.nlm.nih.gov/pubmed/22499055

Sie P, Samama CM, Godier A, Rosencher N, Steib A, Llau JV, . . . Albaladejo P (2011) Surgery and invasive procedures in patients on long-term treatment with direct oral anticoagulants: thrombin or factor-Xa inhibitors. Recommendations of the Working Group on Perioperative Haemostasis and the French Study Group on Thrombosis and Haemostasis. Arch Cardiovasc Dis 104:669-676.
http://www.ncbi.nlm.nih.gov/pubmed/22152517

Tang M, Wierup P, Christiansen K, Greisen J, Sorensen B (2012) Theragnostic performance of ex vivo testing of haemostatic intervention and clinical effect of recombinant factor VIIa and fibrinogen concentrate. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/22475314

Tian M, Wan Y, Tang J, Li H, Yu G, Zhu J, . . . Zhu S (2011) Depletion of tissue factor suppresses hepatic metastasis and tumor growth in colorectal cancer via the downregulation of MMPs and the induction of autophagy and apoptosis. Cancer Biol Ther 12:896-907.
http://www.ncbi.nlm.nih.gov/pubmed/22052255

van Hinsbergh VW (2012) Endothelium--role in regulation of coagulation and inflammation. Semin Immunopathol 34:93-106.
http://www.ncbi.nlm.nih.gov/pubmed/21845431

Wafaisade A, Lefering R, Maegele M, Lendemans S, Flohe S, Hussmann B, . . . Bouillon B (2012) Coagulation management of bleeding trauma patients is changing in German trauma centers: An analysis from the trauma registry of the German Society for Trauma Surgery. J Trauma Acute Care Surg 72:936-942.
http://www.ncbi.nlm.nih.gov/pubmed/22491608

Woei AJFJ, de Kruif MD, Garcia Rodriguez P, Osanto S, Bertina RM (2012) Microparticles expressing tissue factor are concurrently released with markers of inflammation and coagulation during human endotoxemia. J Thromb Haemost.
http://www.ncbi.nlm.nih.gov/pubmed/22489893
__________________________________________________________
ABOUT TRIGGER
TRIGGER is edited by Jim Morrissey and Pierre Neuenschwander, with editorial assistance by Genie Morrissey. It includes Abstracts of Papers in Press, Meeting Announcements, Positions Sought/Available,or any other pertinent item that subscribers may want to share with their colleagues. To submit an item for publication in Trigger, e-mail us. To request or cancel a subscription,or for more information about TRIGGER or the biology of tissue factor and factor VII, visit our web site. You can also contact us by mail: J.H. Morrissey, University of Illinois College of Medicine, 417 Med Sci Bldg MC-714, 506 S. Mathews Ave., Urbana, IL 61801, USA.

DISCLAIMER: TRIGGER is provided "as is" for information purposes only and without warranty of any kind, express or implied. Users shall assume the entire risk as to the accuracy and usefulness of information in TRIGGER. Opinions expressed here are not necessarily those of the editors or their employers. You may share TRIGGER with your scientific colleagues but you are not permitted to use it or its contents for commercial purposes.
__________________________________________________________